Clinical trial
Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
NCT00440713 · Federal University of São Paulo, Other · Completed
Key facts
| NCT number | NCT00440713 |
|---|---|
| Title | Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms |
| Official title | Phase 3 Study of Aripriprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms |
| Acronym | AripipPTSD |
| Lead sponsor | Federal University of São Paulo, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Aripiprazole, Interpersonal Therapy |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Feb 27, 2007 |
| Last update posted | Feb 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: